EcoDrugPlus

Tubulin Alpha Chain-Like

Ensembl ID : ENSCVAG00000014521
Gene Symbol: LOC107086463
2 Cross references
144 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSCVAG00000007718
Gene Symbol: LOC107095079
2 Cross references
174 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSCVAG00000022500
Gene Symbol: LOC107082212
3 Cross references
114 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCVAG00000008856
Gene Symbol: LOC107103221
2 Cross references
183 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCVAG00000022054
Gene Symbol: LOC107092425
3 Cross references
301 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCVAG00000005058
Gene Symbol: TP53
2 Cross references
231 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSCVAG00000015411
Gene Symbol: LOC107101726
3 Cross references
189 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCVAG00000017937
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCVAG00000019658
Gene Symbol: TYR
4 Cross references
196 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSCVAG00000002841
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCVAG00000013846
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCVAG00000004204
Gene Symbol: TIE1
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).